NMTR

Q: What is the price of 9 Meters Biopharma (NMTR) today?

The price of 9 Meters Biopharma (NMTR) today is US$ 0,00, with a variation of 0% compared to the last year. The price of 9 Meters Biopharma (NMTR) started the year trading around US$ 0,00 and today it is at US$ 0,00. Follow the real-time price chart, the historical price of 9 Meters Biopharma (NMTR), and stock data from Ibovespa and international markets.

Q: When does 9 Meters Biopharma (NMTR) pay dividends?

9 Meters Biopharma (NMTR) não distribuiu dividendos no último ano.

Q: 9 Meters Biopharma (NMTR) is it worth it?

Currently, 9 Meters Biopharma (NMTR) is priced at US$ 0,00, with a P/E of 0,06%, representing a deviation of -41,25% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of -357,02%. The total shareholder return was 0,00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of 9 Meters Biopharma (NMTR)?

Investing in stocks of 9 Meters Biopharma (NMTR) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of 9 Meters Biopharma (NMTR) yield today?

The yield of 9 Meters Biopharma (NMTR) was 0,00% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de -357,02%.If you wanted to buy 100 stocks of 9 Meters Biopharma (NMTR) today, the total investment would be US$ 0,00, based on the current price of US$ 0,00.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 0,00In 5 years: US$ 0,00In 10 years: 0,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

9 Meters Biopharma Inc.

This asset is no longer available for investment.

View all assets

Price

US$ -

variation (12m)

0,00%

p/l

0,06

p/vp

0,60

DIVIDEND YIELD

-357,02%

price NMTR

BVMF

NMTR

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of NMTR

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

0,00%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

0,00%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

Indicators NMTR

check out the fundamentals of 9 Meters Biopharma shares

P/E

0,06

Sector: -3,49 Industry: -3,49

P/SALES RATIO (PSR)

Sector: -4,23 Industry: -4,23

P/BV

0,60

Sector: 1,90 Industry: 1,90

DIVIDEND YIELD (DY)

-357,02%

Sector: - Industry: -

ROA

-738,37%

Sector: -63,54% Industry: -63,54%

ROE

1.091,65%

Sector: -70,19% Industry: -70,19%

ROIC

Sector: -2.095,92% Industry: -2.095,92%

NET MARGIN

0,00%

Sector: -41,67% Industry: -41,67%

GROSS MARGIN

0,00%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

0,00%

Sector: -41,04% Industry: -41,04%

P/EBITDA

0,06

Sector: -3,69 Industry: -3,69

P/EBIT

0,06

Sector: -3,68 Industry: -3,68

P/ASSET

-0,41

Sector: 1,42 Industry: 1,42

BVPS

-0,46

Sector: 1,85 Industry: 1,85

EPS

-5,06

Sector: -2,19 Industry: -2,19

EQUITY / ASSETS

-0,68

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

2,26%

Sector: - Industry: -

NMTR indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,99	5,85	32,50%	2,66%	US$ 458,87 B	27,75%
PFE	15,32	1,58	10,33%	6,90%	US$ 140,87 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	15,47	9,74	62,99%	2,96%	US$ 253,17 B	34,74%
MRK	12,21	4,40	36,03%	3,77%	US$ 215,83 B	28,16%
AZN	28,13	5,85	20,79%	1,85%	US$ 262,04 B	16,23%
BMY	17,14	5,05	29,44%	5,67%	US$ 88,25 B	10,71%
GILD	20,79	7,45	35,82%	2,68%	US$ 145,89 B	24,71%
ZTS	23,71	12,62	53,20%	1,37%	US$ 62,79 B	28,00%
HALO	13,25	23,31	175,93%	0,00%	US$ 7,76 B	48,21%
REGN	13,15	1,98	15,06%	0,47%	US$ 59,29 B	31,83%
AMGN	29,90	21,01	70,29%	3,24%	US$ 156,09 B	14,67%
VRTX	28,91	6,10	21,11%	0,00%	US$ 104,80 B	31,22%
MCK	25,75	-110,60	-429,55%	0,39%	US$ 95,44 B	0,97%
CAH	26,89	-14,13	-52,54%	1,30%	US$ 37,22 B	0,60%
ADMA	16,91	8,80	52,03%	0,00%	US$ 3,50 B	43,51%
BIIB	12,13	1,22	10,08%	0,00%	US$ 21,55 B	17,46%

comparison of NMTR with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History NMTR

current DY: -357,02%

5-year average DY: -142,43%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	28/06/2024	29/07/2024	0,20000000
Dividends	25/03/2024	25/04/2024	0,20000000
Dividends	26/12/2023	26/01/2024	0,20000000
Dividends	21/09/2023	26/10/2023	0,30000000
Dividends	16/06/2023	26/07/2023	0,30000000
Dividends	20/03/2023	26/04/2023	0,40000000
Dividends	27/12/2022	26/01/2023	0,25440000
Dividends	26/09/2022	26/10/2022	0,01280000
Dividends	27/06/2022	25/07/2022	0,25600000
Dividends	24/03/2022	25/04/2022	0,25600000
Dividends	27/12/2021	25/01/2022	0,27200000
Dividends	23/09/2021	25/10/2021	0,27200000
Dividends	24/06/2021	26/07/2021	0,27200000
Dividends	25/03/2021	26/04/2021	0,27200000
Dividends	17/12/2020	25/01/2021	0,08000000
Dividends	24/09/2020	26/10/2020	0,06400000
Dividends	01/07/2020	27/07/2020	0,04000000
Dividends	20/12/2019	27/01/2020	0,80000000
Dividends	19/09/2019	25/10/2019	0,80000000
Dividends	24/06/2019	25/07/2019	0,80000000
Dividends	29/03/2019	25/04/2019	0,80000000
Dividends	14/12/2018	25/01/2019	0,80000000
Dividends	27/09/2018	26/10/2018	0,80000000
Dividends	28/06/2018	26/07/2018	0,80000000
Dividends	29/03/2018	26/04/2018	0,80000000
Dividends	18/12/2017	25/01/2018	0,80000000
Dividends	25/09/2017	25/10/2017	0,80000000
Dividends	26/06/2017	25/07/2017	0,80000000
Dividends	27/03/2017	25/04/2017	0,80000000
Dividends	27/12/2016	26/01/2017	0,96000000
Dividends	26/09/2016	28/10/2016	0,96000000

ABOUT THE COMPANY 9 Meters Biopharma

9 Meters Biopharma Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

15 years

Foundation: 2010

2016

Year of debut on the stock exchange - 9 years

12

Employees

The Company 9 Meters Biopharma Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ -3,81 Milhões, having a net worth of $ -6,30 Milhões.

With a total of 12 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -68,76 Milhões.

As for its main indicators, the Company has a P/E ratio of 0,06, a P/BV ratio of 0,60 and in the last 12 months the dividend yield of NMTR was at -357,02%.

The Company is traded internationally through the ticker NMTR.

Market value

US$ -3,81 Milhões

Net worth

US$ -6,30 Milhões

US$ -6.299.205,00

Assets

US$ 9,31 Milhões

US$ 9.313.037,00

Total Number of Shares

13,59 Milhões

13.591.000

Average Daily Trading Volume

US$ 66,60 Thousand

US$ 66.598,00

Sector

Health Care

Industry

Biotechnology

NMTR

NMTR revenue and profits

NMTR results

DRAG THE FRAME TO SEE MORE DATA

NMTR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

NMTR

9 Meters Biopharma Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of NMTR

check out the fundamentals of 9 Meters Biopharma shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: -357,02%

5-year average DY: -142,43%

type

date with

payment date

value

ABOUT THE COMPANY 9 Meters Biopharma

9 Meters Biopharma Inc.

Estados Unidos

15 years

2016

12

PROFIT X PRICE NMTR

NMTR results

NMTR cash flow

evolution of assets - NMTR

NMTR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions